SCHEMBL23782284

SCHEMBL23782284

O=Cc1nc2c(CC(F)(F)F)cccc2[nH]1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GNRHR P30968 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PARP1 P09874 3/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ADAMTS5 Q9UNA0 2/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ GRIN2B Q13224 1/20 0.31
▸ DRD2 P14416 1/20 0.30
▸ DRD4 P21917 1/20 0.30
▸ DRD3 P35462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23800777 0.77 PARP1 (0.42) KDM4EHPGDPARP1MEN1POLB
SCHEMBL23782282 0.75 KDM4E (0.34) KDM4EHPGDPARP1MEN1POLB
SCHEMBL2767156 0.74 EGLN1 (0.42) PARP1GAAL3MBTL1ADAMTS5
SCHEMBL30181199 0.73 DRD2 (0.37) GNRHRKDM4EHPGDPARP1MEN1
SCHEMBL23782219 0.73 DRD2 (0.37) GNRHRKDM4EHPGDPARP1MEN1
Hydrochloric Acid SCHEMBL25221123 0.73 EGLN1 (0.41) PARP1MEN1POLBGAAMAPT
SCHEMBL9675516 0.71 DUT (0.34) ADAMTS5
SCHEMBL1768203 0.71 ADAMTS5 (0.55) GAATDP1ADAMTS5
SCHEMBL23782273 0.71 CYP2A6 (0.41) KDM4EHPGDPARP1MEN1GAA
SCHEMBL30180820 0.71 ADAMTS5 (0.55) GAATDP1ADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4114837-A1 PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12 Bayer Aktiengesellschaft (DE) 2023-01-11 — — EP disclosed
WO-2021176049-A1 PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12 BAYER AKTIENGESELLSCHAFT (DE) 2021-09-10 — — WO disclosed
Send feedback